During their retrospective analysis of squamous cell carcinomas of head and neck (HNSCC), Zhou and colleagues reported that low POLH expression was significantly associated with high complete response rate (p = 0.03) in patients treated with platinum- and gemcitabine-based chemotherapy [60]. The gene discussed is POLH; the disease is head and neck squamous cell carcinoma.